Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by kuatolives

T.MSL

RE:TRUMP = ?

Merus is, unfortunately, a backwater pharma with limited growth prospects...

November 11, 2016

V.BTI.H

RE:RE:RE:RE:RE:RE:RE:RE:who is selling over 200 thousand shares at $1.35 today

I follow this stock only passively (no position), but the drop since the...

November 11, 2016

T.QIPT

RE:How come a basket...

The broader biotech rally since the Trump win is applying to the larger...

November 11, 2016

ARLZQ

Zack's update

Short version: $11 http://scr.zacks.com/News/Press-Releases/Press-Release...

November 10, 2016

ARLZQ

RE:RE:RE:RE:RE:Woo!

We'll start seeing some green now, I think, a bit earlier than the Q4...

November 10, 2016

ARLZQ

RE:RE:RE:Woo!

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica} p.p2 {margin...

November 9, 2016

ARLZQ

Toprol XL Price Increase?

I wonder if this will happen now....

November 9, 2016

ARLZQ

RE:Woo!

I wonder if this is a return to the price increases of the last couple of...

November 9, 2016

ARLZQ

RE:RE:Big pharma back in business?

Not sure it matters if the sketchy pharma practices of last year are allowed...

November 9, 2016

ARLZQ

Big pharma back in business?

Who'da thought that bozo would win the white house. Guess that'll be...

November 9, 2016

ARLZQ

Concordia and Valeant

Eeeeesh. What a bloodbath. Glad the sector has finally unhinged itself from...

November 8, 2016

ARLZQ

RE:Understated Revenue?

ahhh found it. Toprol revenue doesn't appear to accumulate until Oct 31st...

November 7, 2016

ARLZQ

Understated Revenue?

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica} p.p2 {margin...

November 7, 2016

ARLZQ

RE:RE:RE:RE:RE:RE:50 Yosprala scripts per/wk... according to the CC..

Just saying, at $150/bottle for 30 pills, that's $1800 a year per patient...

November 7, 2016

ARLZQ

RE:RE:RE:RE:50 Yosprala scripts per/wk... according to the CC..

Scripts are typically accumulative, so that adds up fast.

November 7, 2016

ARLZQ

RE:RE:50 Yosprala scripts per/wk... according to the CC..

They compared the uptake with some other cardio drugs that hit the market in...

November 7, 2016

ARLZQ

50 Yosprala scripts per/wk... according to the CC..

In line with other comparable drug launches.... apparantly.

November 7, 2016

ARLZQ

Monday Math ..

If Yosprala can make 25 million in 2017, that'll put revenues around: 25...

October 31, 2016

ARLZQ

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TRX

I would just like to re-iterate, that companies that pay off the most will...

October 27, 2016

ARLZQ

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TRX

I don't disagree with much of what was said either, I'm just...

October 27, 2016

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Alphamin Resources Corp.

Alphamin Resources Corp. V.AFM

Alphamin Resources Corp. is a Mauritius-based company, which is engaged in the production and sale of tin concentrate from ... view more »